Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Kaufman

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Clinical Lymphoma, Myeloma & Leukemia|October 8, 2013
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphomaRajni Sinha, Pareen J Shenoy, Nassoma King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding studySagar Lonial, Jonathan Kaufman, Mourad Tighiouart, et al.
Neuron|November 24, 2018
Interactions between the Ig-Superfamily Proteins DIP-α and Dpr6/10 Regulate Assembly of Neural CircuitsShuwa Xu, Qi Xiao, Filip Cosmanescu, et al.
Transfusion|June 10, 2010
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host diseaseMojtaba Akhtari, Cynthia R Giver, Zahir Ali, et al.
Science Signaling|November 19, 2009
Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growthTaro Hitosugi, Sumin Kang, Matthew G Vander Heiden, et al.
JCO Precision Oncology|December 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) FusionsTejas Patil, Jessica J Lin, Parneet K Cheema, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Clinical Lymphoma, Myeloma & Leukemia|October 8, 2013
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphomaRajni Sinha, Pareen J Shenoy, Nassoma King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding studySagar Lonial, Jonathan Kaufman, Mourad Tighiouart, et al.
Neuron|November 24, 2018
Interactions between the Ig-Superfamily Proteins DIP-α and Dpr6/10 Regulate Assembly of Neural CircuitsShuwa Xu, Qi Xiao, Filip Cosmanescu, et al.
Transfusion|June 10, 2010
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host diseaseMojtaba Akhtari, Cynthia R Giver, Zahir Ali, et al.
Science Signaling|November 19, 2009
Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growthTaro Hitosugi, Sumin Kang, Matthew G Vander Heiden, et al.
JCO Precision Oncology|December 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) FusionsTejas Patil, Jessica J Lin, Parneet K Cheema, et al.
Pageof 8